Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | +1.94% |
|
-6.25% | +19.32% |
Business Summary
Number of employees: 12
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 30/11/08 |
Steven Quay
CEO | Chief Executive Officer | 73 | 30/11/08 |
Heather Rees
DFI | Director of Finance/CFO | 51 | 31/12/16 |
Arezoo Mirad
CTO | Chief Tech/Sci/R&D Officer | - | 12-03 |
Richard Graydon
CTO | Chief Tech/Sci/R&D Officer | - | 24/10/22 |
Delly Behen
ADM | Chief Administrative Officer | - | 31/12/13 |
Eric van Zanten
IRC | Investor Relations Contact | - | 06/12/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 30/11/08 |
Director/Board Member | 66 | 28/02/14 | |
H. Remmel
BRD | Director/Board Member | 72 | 31/01/12 |
Shu-Chih Chen
FOU | Founder | 62 | 30/11/08 |
Stephen Galli
BRD | Director/Board Member | 77 | 30/06/11 |
Jonathan Finn
BRD | Director/Board Member | 50 | 11-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 127,077,462 | 125,684,004 ( 98.90 %) | 1,320,046 ( 1.039 %) | 98.90 % |
Stock B | 0 | 582 | 0 | 0 |
Company contact information
Atossa Therapeutics, Inc.
107 Spring Street
98104, Seattle
+206 588 0256
http://www.atossatherapeutics.com![address Atossa Therapeutics, Inc.(ATOS)](https://cdn.zonebourse.com/static/address/42859369.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.32% | 132M | |
+23.13% | 46.93B | |
+37.49% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |
- Stock Market
- Equities
- ATOS Stock
- Company Atossa Therapeutics, Inc.